Vir Biotechnology, Inc. is a company in the U.S. stock market and it is a holding in 90 U.S.-traded ETFs. VIR has around 19.1M shares in the U.S. ETF market. The largest ETF holder of VIR is the iShares Core S&P Small-Cap ETF (IJR), with approximately 5.41M shares. Investors may also find of interest that the ETF with the largest allocation to VIR stock is ETFMG Treatments Testing and Advancements ETF (GERM), with a portfolio weight of 4.27%. On average, U.S. ETFs allocate 0.36% of VIR to their portfolios.

Additionally, VIR is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with VIR as a holding is the First Trust Active Factor Small Cap ETF (AFSM), with a return of --.